Context Therapeutics Inc [CNTX] stock is trading at $1.4, up 22.81%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CNTX shares have gain 40.04% over the last week, with a monthly amount glided 64.67%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Context Therapeutics Inc [NASDAQ: CNTX] stock has seen the most recent analyst activity on September 18, 2025, when Guggenheim initiated its Buy rating and assigned the stock a price target of $5. On January 08, 2025, JMP Securities initiated with a Mkt Outperform rating and assigned a price target of $4 on the stock. D. Boral Capital started tracking the stock assigning a Buy rating and suggested a price target of $9 on November 25, 2024. Piper Sandler initiated its recommendation with a Overweight and recommended $4.50 as its price target on May 16, 2024.
Context Therapeutics Inc [CNTX] stock has fluctuated between $0.49 and $2.59 over the past year. Currently, Wall Street analysts expect the stock to reach $5.25 within the next 12 months. Context Therapeutics Inc [NASDAQ: CNTX] shares were valued at $1.4 at the most recent close of the market. An investor can expect a potential return of 275.0% based on the average CNTX price forecast.
Analyzing the CNTX fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.39, Equity is -0.39 and Total Capital is -0.46. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.2267 points at the first support level, and at 1.0534 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.5066, and for the 2nd resistance point, it is at 1.6132.
Ratios To Look Out For
For context, Context Therapeutics Inc’s Current Ratio is 19.04. As well, the Quick Ratio is 19.04, while the Cash Ratio is 18.33.
Transactions by insiders
Recent insider trading involved Lehr Martin A., Chief Executive Officer, that happened on Jun 09 ’25 when 100000.0 shares were purchased. Chief Legal Officer, Corp. Sec, Levit Alex C. completed a deal on Jun 06 ’25 to buy 20000.0 shares. Meanwhile, Chief Financial Officer Minai-Azary Jennifer Lynn bought 40010.0 shares on Jun 06 ’25.
